The Carlos III Health Institute (ISCIII) presented last Thursday, July 4, 3 new calls for the development of Clinical Research Units (UiC), Precision Medicine and Research into Rare Diseases and Neuromuscular Pathologies.

For the Call for Clinical Research Units, 45 million euros will be provided to finance the creation or consolidation of these structures, which promote the performance of clinical trials.

In the ISCIII Call for Personalized Precision Medicine, grants worth 25 million euros will be awarded in coordination with the activity of the IMPaCT Infrastructure.

Finally, for the ISCIII Call for Rare Diseases and Neuromuscular Pathologies/ALS, grants worth 20 million euros will be allocated to improve prevention, diagnosis and treatment with precision medicine.